Impact of the COVID-19 Pandemic on Surgical Oncology in Europe: Results of a European Survey.
Adult
Ambulatory Care
/ statistics & numerical data
COVID-19
/ diagnosis
Chemotherapy, Adjuvant
/ statistics & numerical data
Cross-Sectional Studies
Europe
/ epidemiology
Female
Hospital Bed Capacity
/ statistics & numerical data
Humans
Male
Middle Aged
Neoplasms
/ diagnosis
Oncology Service, Hospital
/ statistics & numerical data
Operating Rooms
/ statistics & numerical data
Surgical Oncology
/ statistics & numerical data
Surveys and Questionnaires
Survival Rate
Time-to-Treatment
/ statistics & numerical data
COVID-19 pandemic
European surgery
Surgical care
Surgical oncology
Journal
Digestive surgery
ISSN: 1421-9883
Titre abrégé: Dig Surg
Pays: Switzerland
ID NLM: 8501808
Informations de publication
Date de publication:
2021
2021
Historique:
received:
02
09
2020
accepted:
03
02
2021
pubmed:
1
6
2021
medline:
24
9
2021
entrez:
31
5
2021
Statut:
ppublish
Résumé
The first COVID-19 pandemic wave hit most of the health-care systems worldwide. The present survey aimed to provide a European overview on the COVID-19 impact on surgical oncology. This anonymous online survey was accessible from April 24 to May 11, 2020, for surgeons (n = 298) who were contacted by the surgical society European Digestive Surgery. The survey was completed by 88 surgeons (29.2%) from 69 different departments. The responses per department were evaluated. Of the departments, 88.4% (n = 61/69) reported a lower volume of patients in the outpatient clinic; 69.1% (n = 47/68) and 75.0% (n = 51/68) reported a reduction in hospital bed and the operating room capacity, respectively. As a result, the participants reported an average reduction of 29.3% for all types of oncological resections surveyed in this questionnaire. The strongest reduction was observed for oncological resections of hepato-pancreatico-biliary (HPB) cancers. Of the interviewed surgeons, 68.7% (n = 46/67) agreed that survival outcomes will be negatively impacted by the pandemic. The first COVID-19 pandemic wave had a significant impact on surgical oncology in Europe. The surveyed surgeons expect an increase in the number of unresectable cancers as well as poorer survival outcomes due to cancellations of follow-ups and postponements of surgeries.
Sections du résumé
BACKGROUND
BACKGROUND
The first COVID-19 pandemic wave hit most of the health-care systems worldwide. The present survey aimed to provide a European overview on the COVID-19 impact on surgical oncology.
METHODS
METHODS
This anonymous online survey was accessible from April 24 to May 11, 2020, for surgeons (n = 298) who were contacted by the surgical society European Digestive Surgery. The survey was completed by 88 surgeons (29.2%) from 69 different departments. The responses per department were evaluated.
RESULTS
RESULTS
Of the departments, 88.4% (n = 61/69) reported a lower volume of patients in the outpatient clinic; 69.1% (n = 47/68) and 75.0% (n = 51/68) reported a reduction in hospital bed and the operating room capacity, respectively. As a result, the participants reported an average reduction of 29.3% for all types of oncological resections surveyed in this questionnaire. The strongest reduction was observed for oncological resections of hepato-pancreatico-biliary (HPB) cancers. Of the interviewed surgeons, 68.7% (n = 46/67) agreed that survival outcomes will be negatively impacted by the pandemic.
CONCLUSION
CONCLUSIONS
The first COVID-19 pandemic wave had a significant impact on surgical oncology in Europe. The surveyed surgeons expect an increase in the number of unresectable cancers as well as poorer survival outcomes due to cancellations of follow-ups and postponements of surgeries.
Identifiants
pubmed: 34058733
pii: 000515186
doi: 10.1159/000515186
pmc: PMC8247801
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
259-265Informations de copyright
© 2021 S. Karger AG, Basel.